Screening of Patients Admitted to a Local Hospital With Pocket-sized Ultrasound
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01081210|
Recruitment Status : Completed
First Posted : March 5, 2010
Last Update Posted : March 30, 2011
Ultrasound (US) is widely used as a diagnostic tool in a hospital setting. In a medical department, diagnosis like heart failure or most kinds of heart diseases, hypervolemia, hypovolemia, pleural effusion, pericardial effusion, ascites, diseases in the gall bladder/bile tract, urine tract and venous thrombosis are common. US is the key diagnostic tool in these diagnosis, and on early diagnosis is crucial both on behalf of the patients well-being, and for hospital logistic reasons.
The aim is to study the clinical use of pocket sized US as a screening diagnostic tool in an department of internal medicine.
Method: All patients admitted (in certain preset periods) to Department of medicine will be screened with pocket sized US by expert user. Changes in diagnoses, as well as medications as a result of US screening will be the endpoints. US findings will be validated against standard echocardiography, or standard US/CT/MRI performed at the Radiological department.
The aim is to study the clinical use of pocket sized US as a screening diagnostic tool in a department of cardiology.
Method: All patients admitted (in certain preset periods) to Department of cardiology will be screened with pocket sized US for heart disease, pericardial and pleural effusion. Examinations by expert users. Specific findings could be myocardial dysfunction as heart failure, cardiomyopathies, regional dysfunction due to ischemia, valvular dysfunction, atrial enlargement, and pleural/pericardial effusion. Changes in diagnoses, as well as medications as a result of US screening will be the endpoints. US findings will be validated against standard echocardiography in all.
- As in 1), but examination by non-expert users compared to expert users.
|Condition or disease||Intervention/treatment|
|Heart Disease Dyspnea Aortic Disease Kidney Disease Liver Disease||Other: Ultrasound examination|
|Study Type :||Observational|
|Estimated Enrollment :||400 participants|
|Official Title:||Screening With Pocket-sized Ultrasound of Patients Admitted to Department of Medicine at a Local Hospital|
|Study Start Date :||March 2010|
|Actual Primary Completion Date :||September 2010|
|Actual Study Completion Date :||October 2010|
Patients admitted to Department of medicine at local hospital. Randomized inclusion, informed consent obtained.
Other: Ultrasound examination
Screening with bedside ultrasound examination
Other Name: GE Vingmed VScan
- Diagnostic sensitivity and specificity [ Time Frame: After 3-6 months ]Diagnostic accuracy and clinical usefulness of ultrasound screening as add on examination. Change in working diagnosis after ultrasound examination will be tested, and gold standards (echocardiography and examinations at Department of radiology) will be used for testing of sensitivity and specificity.
- Non-experts [ Time Frame: After 3-6 months ]Validation of results from ultrasound examination made by non-experts compared to expert users.
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01081210
|Department of Medicine, Levanger Hospital, Nord-Trøndelag Health Trust|
|Levanger, Norway, 7600|
|Levanger Hospital, Department of Medicine|
|Levanger, Norway, N-7600|
|Principal Investigator:||Havard Dalen, MD||Nord-Trøndelag Health Trust|